Effects of Tolperisone on Measures of Drowsiness and Cognitive Function
Clinical trial NCT04407377 · COMPLETED
Trial details
- NCT number
- NCT04407377
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2020-10-16
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.